REGGIO EMILIA. The start of the third dose for 12-15 year olds four months after the completion of the primary cycle, the exit from the periods of isolation and quarantine through the carrying out of rapid antigenic swabs in the pharmacy starting from Monday 10 January, with the cost to be borne of the health service and, from 17 January, the possibility in case of a rapid positive swab performed at home, to immediately start the period of isolation by recording the test result in a special regional portal, uploading the photo of the result itself, and therefore without waiting the times of the healthcare company.
These are the measures that the regional councilor for health policies, Raffaele Donini, spoke about today in a video press conference.
Rapid test in pharmacy for isolation / quarantine closure. With an agreement being defined with the pharmacy associations, from Monday 10 January in Emilia-Romagna people without Covid 19 symptoms can go to partner pharmacies to perform the rapid nasal antigen test. They will be able to do so as long as they fall within the following cases: to carry out a control screening or, if asymptomatic and in quarantine for having had close contact with a Covid case, to close the quarantine period itself (within 24 hours they will receive automatically from health company the report of the closure of the case and reactivation of the Green pass).
If the test is positive for these people, they will be able to carry out the rapid nasal antigen test always in the pharmacy after 10 days for the closure of the isolation period or after 7 days in the case of a person vaccinated with a third dose (booster), which has completed primary school or recovered from Covid, again for less than 4 months.
Swabs performed for quarantine closure or isolation are the responsibility of the Health Service. The agreement with pharmacies also includes a point relating to schools. In fact, first and second grade secondary school students in whose class a COVID case has occurred will be able to do the rapid antigen test, at the request of the general practitioner or pediatrician. In particular, they will be able to take the first test when the presence of a positive is detected and the second test five days after the first. The buffer will be borne by the commissioner.
Self-test: immediate start of the quarantine with self-made quick test. For people who have performed the rapid nasal antigen test at home on their own, in the event of a positive result, there will be the possibility of recording the results of the self-test on a special portal of the Region – active from 17 January -, immediately starting the period of isolation.
In this case, only one of the rapid tests valid in the pharmacy can be used. Furthermore, the people who will be able to resort to this opportunity will have to fall into the following cases: have already received the second vaccination dose, regardless of the date of administration; have activated the electronic health record (ESF) or, in the case of minors, be associated with the parent’s ESF.
The result will be uploaded by inserting the photo with the test result, the choice of the test used from the list of valid ones, information on the behavior to be followed in the event of symptoms appearing, information on the type of certificate that will be sent on the ESF by the Departments of Public Health.
The people who will be able to do the self-test in Emilia-Romagna are about 2.5 million, all those that is have completed the primary vaccination course. In this way, it will be impossible to self-test for those who did not want to vaccinate for contrary to the procedure.
Off to third doses for 12-15 year olds. Third doses also start for the 12-15 age group for girls and boys who have completed the primary cycle for at least four months. In the province of Reggio Emilia it will not be necessary to book but the Ausl will directly send the sms to those entitled, with the first administrations always starting on Monday.
The new recipients of the ‘booster’ recall are defined by a circular from the Ministry of Health, which was followed by a communication from the Regional Department of Health Policies which clarified additional operational aspects to the Health Authorities.
The vaccine planned for the third booster dose in these categories will be Pfizer Biontech’s Comirnaty.